KinaSense is helping to save lives in the battle against cancer by developing innovative tools for drug discovery and clinical applications.
KinaSense is an pre-seed biotechnology company developing a revolutionary drug development platform. We plan to achieve early, low barrier revenue through an initial applications in preclinical drug discovery. This will validate our technology and provide non-dilutive revenue to support clinical applications in personalized diagnostics. We are currently supported by an NIH Phase I SBIR grant.